H.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PT
The reiteration is based on the company's Sonelokimab candidate, which is currently in Phase 3 with topline data release anticipated soon.
A close-up of a biopharmaceutical research laboratory, with a microscope in the foreground.
Selvaraju highlighted the upcoming release of top-line data from the Phase 3 VELA program for Sonelokimab as a major catalyst for the company. The company reported rapid enrollment in this trial, which was faster than industry norms. The analyst believes the company has a huge market opportunity for Sonelokimab, estimating it could address a $10 billion to $15 billion market.
While mentioning the financials, Selvaraju noted MoonLake Immunotherapeutics (NASDAQ:MLTX) had reserves of about $480 million as of early 2025 and also secured a term loan facility of up to $500 million giving runway till 2028 without immediate equity dilution.
MoonLake Immunotherapeutics (NASDAQ:MLTX) is a clinical-stage biopharmaceutical company specializing in the development of medicines for immunologic diseases. Sonelokimab is its key candidate for treating diseases caused by immune system dysfunction, such as inflammatory skin diseases and joint diseases.
While we acknowledge the potential of MLTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MLTX and that has 100x upside potential, check out our report about the .
READ NEXT: and .
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
7 minutes ago
- Fast Company
The fellowship offering job-hunting grads an AI training lifeline
In early March, Volkan Çinar, a chemistry postdoc at MIT, received an email recruiting him to train AI models. Çinar studies carbon-carbon bonds formation in graphene. Given the stiff competition for jobs in academia, Çinar was no longer sure if his dream of working in academia made sense. So he was receptive to the email's pitch. The email came from Handshake, the job search platform which connects 18 million students from 1,600 higher ed institutions to career opportunities, introducing its new MOVE (Model Validation Expert) Fellowship. The new program gives Handshake an entrée into the high end of AI model training, the hot sector that's seen Meta acquire a 49% stake in Scale for more than $14 billion and Surge bootstrap itself to $1 billion in revenue. For talent like Çinar, MOVE offers better money than teaching and comes with AI training. 'I'd never considered working in AI,' Çinar says. 'But given that I'm exploring other positions, I thought I'd give it a try,' even if it meant the risk of paving the road for AI models to take over his field. What to expect from the program The Fellowship's acceptance rate and pay range How to make yourself competitive for an AI gig A better way to source expert talent for AI labs
Bloomberg
8 minutes ago
- Bloomberg
WeRide Vows to Boost Spending to Bring Robotaxis to the World
WeRide Inc. plans to ramp up spending, even as it continues to post losses, as the Chinese autonomous driving company bets that its ambitious international expansion plans will eventually see it reach profitability. 'We are never hesitant in investing in cloud computing, AI computing infrastructure and AI talent,' founder and Chief Executive Officer Tony Han said in an interview on Friday. 'We are determined to spend and build out our sales network' and work with other firms to push for expansion, he said.
Yahoo
14 minutes ago
- Yahoo
Charter Communications, Inc. (CHTR)'s Management Is 'Dreaming,' Says Jim Cramer
We recently published . Charter Communications, Inc. (NASDAQ:CHTR) is one of the stocks Jim Cramer recently discussed. Charter Communications, Inc. (NASDAQ:CHTR) is one of the biggest broadband and cable services providers in America. The fact that its shares are down by 18% is unsurprising since traditional, linear media companies have continued to struggle in today's digitally-driven market. However, Charter Communications, Inc. (NASDAQ:CHTR) might have fared much better had it not been for a disastrous 28% share price drop in July. The firm's shares fell after the firm's latest earnings report revealed that its internet customers continued to drop. Cramer discussed the earnings call: 'I mean when I read through the Charter conference call, there seemed to be a disbelief. They're like don't worry, everything is great. And they talked about all the things that are great. But the market thought that the quarter was awful. And, I think the market is the arbiter, not the management of Charter. They're dreaming. They're dreaming. I mean they're in cable.' Photo by Mika Baumeister on Unsplash Here's what Charter Communications, Inc. (NASDAQ:CHTR)'s management said about its subscribers during the earnings call: 'Including residential and small business, we lost 117,000 Internet customers in the still seasonal second quarter, compared to a loss of about 100,000 in last year's 2Q when adjusted to remove last year's impact of about 50,000 ACP-related disconnects. When comparing this year's second quarter Internet net adds versus last year's 2Q, we have not adjusted our second quarter 2024 Internet net adds for the 50,000 ACP-related gross adds headwind we called out last year when comparing to 2023 as neither the second quarter of 2025, nor 2024 had the benefit of ACP-related gross additions.' While we acknowledge the potential of CHTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
